skip to main content

Pierce elected president of American Society of Clinical Oncology

Date Visible: 
12/18/2018 - 2:45pm

Media contact:  Nicole Fawcett,  734-764-2220 |  Patients may contact Cancer AnswerLine,  800-865-1125

Term begins in June as president-elect of largest cancer society

ANN ARBOR, Michigan — University of Michigan Rogel Cancer Center member Lori Pierce, M.D., was elected president of the American Society of Clinical Oncology.

The four-year appointment begins with Pierce becoming president-elect in June 2019. She will serve a one-year term as president beginning June 2020.

ASCO is the largest and one of the most influential oncology professional societies, with nearly 45,000 members around the globe.

“I am honored to be elected as the next ASCO president and will aim to use my varied leadership experience within ASCO and beyond to cultivate collaboration within our field, strategize new treatment approaches and efficiencies in cancer care, and continue to emphasize high quality care,” says Pierce, professor of radiation oncology at Michigan Medicine and vice provost for academic and faculty affairs at the University of Michigan.

A national leader in breast cancer research, Pierce serves as director of the Michigan Radiation Oncology Quality Consortium. She completed her medical degree at Duke University, her internship at the Thomas Jefferson University Hospital and her residency at the University of Pennsylvania.

Pierce has served on the ASCO board of directors and is currently chair of the Conquer Cancer Foundation Nominating Committee and a member of the ASCO Special Awards Selection Committee. Pierce is a past member of multiple ASCO committees including the Government Relations Committee and Scientific Program Committee. She served as a mentor for the Leadership Development Program and this year received the Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award. She was named a Fellow of ASCO (FASCO) in 2015.